Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Small Methods
|
June 14, 2023
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection
Dongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Biorxiv : the Preprint Server for Biology
|
September 12, 2022
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity
Dongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Cancer Discovery
|
January 9, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants
Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, et al.
Blood Advances
|
January 9, 2025
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study
Othman Salim Akhtar, Temitope Oloyede, Ruta Brazauskas, et al.
Blood
|
April 8, 2025
Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis
Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar, et al.
Transplantation and Cellular Therapy
|
April 9, 2021
Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults
Asmita Mishra, Jaime M Preussler, Vijaya Raj Bhatt, et al.
Blood Cancer Journal
|
April 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Doris K Hansen, Danai Dima, Hira Mian, et al.
British Journal of Haematology
|
September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study
Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Transplantation and Cellular Therapy
|
February 17, 2025
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines
Pashna N Munshi, Rebecca L Olin, Sarah Wall, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Small Methods
|
June 14, 2023
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine Protection
Dongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Biorxiv : the Preprint Server for Biology
|
September 12, 2022
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity
Dongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Cancer Discovery
|
January 9, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell Transplants
Jinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, et al.
Blood Advances
|
January 9, 2025
Outcomes of older adults and frail patients receiving idecabtagene vicleucel: a CIBMTR study
Othman Salim Akhtar, Temitope Oloyede, Ruta Brazauskas, et al.
Blood
|
April 8, 2025
Standard-of-Care Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis
Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar, et al.
Transplantation and Cellular Therapy
|
April 9, 2021
Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults
Asmita Mishra, Jaime M Preussler, Vijaya Raj Bhatt, et al.
Blood Cancer Journal
|
April 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study
Doris K Hansen, Danai Dima, Hira Mian, et al.
British Journal of Haematology
|
September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study
Celalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Transplantation and Cellular Therapy
|
February 17, 2025
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines
Pashna N Munshi, Rebecca L Olin, Sarah Wall, et al.
Leukemia & Lymphoma
|
September 3, 2021
Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
Jan Philipp Bewersdorf, Andriy Derkach, Lohith Gowda, et al.
Page
of 6